<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04742179</url>
  </required_header>
  <id_info>
    <org_study_id>11/2020</org_study_id>
    <nct_id>NCT04742179</nct_id>
  </id_info>
  <brief_title>Fighting Climate Change: Urban Greennes, Active Mobility and Health Co-benefits.</brief_title>
  <official_title>Fighting Climate Change: Urban Greennes, Active Mobility and Health Co-benefits.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto per la Ricerca e l'Innovazione Biomedica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto per la Ricerca e l'Innovazione Biomedica</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, non-randomized, controlled, interventional study aiming to assess, in&#xD;
      a primary school in the city of Palermo, the health effects of a maintenance and care&#xD;
      intervention of the school's green areas.&#xD;
&#xD;
      All children of the third, fourth and fifth classes of two school complexes of the same&#xD;
      primary school will be selected. One complex will undergo maintenance and care of the green&#xD;
      areas and gardens inside the school. The other complex will serve as a control group and will&#xD;
      not undergo any intervention.&#xD;
&#xD;
      The study will involve three phases.&#xD;
&#xD;
        1. During the first phase (prior to the intervention) respiratory and allergic symptoms&#xD;
           will be assessed through a standardized questionnaire to be administered to students,&#xD;
           parents and teachers in both the school complexes.&#xD;
&#xD;
        2. During the second phase, the maintenance and care intervention plan will be implemented&#xD;
           in the experimental complex.&#xD;
&#xD;
        3. During the third phase, 1 week after the maintenance intervention, respiratory and&#xD;
           allergic symptoms will be re-assessed through a standardized questionnaire to be&#xD;
           administered to the same students, parents and teachers in both the school complexes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 11, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Asthma symptoms at baseline</measure>
    <time_frame>Before the maintenance intervention</time_frame>
    <description>Presence of asthma symptoms before the maintenance intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rhinitis symptoms at baseline</measure>
    <time_frame>Before the maintenance intervention</time_frame>
    <description>Presence of rhinitis symptoms before the maintenance intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Conjunctivitis symptoms at baseline</measure>
    <time_frame>Before the maintenance intervention</time_frame>
    <description>Presence of conjunctivitis symptoms before the maintenance intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Asthma symptoms at follow-up</measure>
    <time_frame>7 days after the maintenance intervention</time_frame>
    <description>Presence of asthma symptoms after the maintenance intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rhinitis symptoms at follow-up</measure>
    <time_frame>7 days after the maintenance intervention</time_frame>
    <description>Presence of rhinitis symptoms after the maintenance intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Conjunctivitis symptoms at follow-up</measure>
    <time_frame>7 days after the maintenance intervention</time_frame>
    <description>Presence of conjunctivitis symptoms after the maintenance intervention</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Respiratory and Allergic Symptoms</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The children belonging to the classes of the school complex undergoing the maintenance intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The children belonging to the classes of the school complex that will not undergo the maintenance intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Manteinance and care intervention on the green areas.</intervention_name>
    <description>Manteinance and care intervention on the green areas.</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  male or female gender&#xD;
&#xD;
          -  age between 7 and 11 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  no exclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stefania La Grutta, MD</last_name>
    <phone>0916809194</phone>
    <email>stefania.lagrutta@irib.cnr.it</email>
  </overall_contact>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 28, 2021</study_first_submitted>
  <study_first_submitted_qc>February 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2021</study_first_posted>
  <last_update_submitted>February 2, 2021</last_update_submitted>
  <last_update_submitted_qc>February 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istituto per la Ricerca e l'Innovazione Biomedica</investigator_affiliation>
    <investigator_full_name>Stefania La Grutta, MD</investigator_full_name>
    <investigator_title>Research Manager</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

